-+ 0.00%
-+ 0.00%
-+ 0.00%

Actuate Therapeutics Reports Phase 2 Trial Success for Elraglusib in Metastatic Pancreatic Cancer

Reuters·01/12/2026 13:45:12

Please log in to view news